Loghman Pharmaceuticals

Loghman Pharmaceutical & Hygienic Co.

Company type	Public
Traded as	TSE: DLGM1 ISIN: IRO1DLGM0000
Industry	Medical equipment Pharmaceutical
Founded	1968; 56 years ago (1968)
Headquarters	Tehran, Iran
Area served	Worldwide
Key people	Khosro Davari, chief executive officer Alireza Zohrevand, Chairman
Products	Pharmaceutical drug Ampoule, Tablet (pharmacy), Capsule (pharmacy)
Net income	44 Billion IRR (2009)
Total assets	437 Billion IRR (2009)
Website	www.loghmanpharma.com

Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان, Shirkat-e Darvii-ye vâ Behedashiti-ye Laqman) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of drugs in Iran.[1]

History

Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.[2]

The company has been listed on the Tehran Stock Exchange since 1997.[3]

products

• Acetaminophen+Codeine
• Amoxicillin
• Azithromycin
• Buspirone
• Carbamazepine
• Cefalexin
• Cefazolin
• Cefepime
• Cefixime
• Ceftazidime
• Ceftriaxone
• Cefuroxime
• Cefalexin
• Diazepam
• Erythromycin
• Fluconazole
• Sodium Fluoride
• Ibuprofen
• Indomethacin
• Lorazepam
• Losartan Potassium
• Meropenem
• Methimazole
• Nortriptyline
• Phenytoin
• Sodium Fluoride
• Sorbitol
• Valsartan

Development plan

• Insulin

See also

• Health care in Iran

References

1. "Stocks". Archived from the original on October 5, 2012.
2. "شرکت دارویی بهداشتی لقمان". Archived from the original on 2013-07-08. Retrieved 2013-06-08.
3. "Dlgm1 37,480".